1. From the Ludwig Institute for Cancer Research, Stockholm Branch (K.A., G.v.E., X.L., A.P., B.O., U.E.); the Department of Physiology and Pharmacology, Section of Integrative Cardiovascular Physiology (P.T.) and Microbiology and Tumorbiology Center, Section of Angiogenesis Research (Y.C.), Karolinska Institutet, Stockholm; and the Department of Medical Biochemistry, University of Göteborg, Göteborg (S.G.-M., M.P., C.B.), Sweden; and the Molecular/Cancer Biology Laboratory, Haartman Institute,...